Global Liquid Biopsy Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

Liquid biopsy is the sampling and analysis of non-solid biological tissue, primarily blood. Like traditional biopsy this type of technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer, with the added benefit of being largely non-invasive. The Liquid Biopsy market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Liquid Biopsy market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Liquid Biopsy Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Liquid Biopsy market are: Biocept Foundation Medicine, Inc. Guardant Health Agena Bioscience SAGA Diagnostics AB Inivata Trovagene RainDance Technologies Exosome Diagnostics Qiagen Adaptive Personal Genome Diagnostic Admeria Health Personal Genome Diagnostics Circulogene Theranostics NeoGenomics Laboratories Cynvenio Most important types of Liquid Biopsy products covered in this report are: Blood Urine Other Most widely used downstream fields of Liquid Biopsy market covered in this report are: Breast Cancer Colorectal Cancer Liver Cancer Lung Cancer Prostate Cancer Other Cancers Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.